Nutrient gene interactions in lipid metabolism

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 12, Issue 4, 2009, Pages 357-363

  Minihane, Anne Marie ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

Genotype; Lipid metabolism; n 3 PUFA; Polyunsaturated fatty acids (PUFA); Transcription factors

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; POLYUNSATURATED FATTY ACID; TRANSCRIPTION FACTOR; TRIACYLGLYCEROL;

BODY FAT; FAT INTAKE; GENE IDENTIFICATION; GENE INTERACTION; GENETIC VARIABILITY; GENETICS; GENOTYPE; LIPID BLOOD LEVEL; LIPID COMPOSITION; LIPID METABOLISM; LIPOGENESIS; LIPOPROTEIN METABOLISM; NUTRIENT; NUTRIGENOMICS; REGULATORY MECHANISM; REVIEW; TRIACYLGLYCEROL BLOOD LEVEL;

DIETARY FATS; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; GENOTYPE; HUMANS; LIPID METABOLISM; LIPIDS; NUTRIGENOMICS; NUTRITIONAL PHYSIOLOGICAL PHENOMENA;

EID: 68049094116     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e32832c94a5     Document Type: Review

References (45)

1. Corthesy-Theulaz I, den Dunnen JT, Ferre P, et al. Nutrigenomics: the impact of biomics technology on nutrition research. Ann Nutr Metab 2005; 49:355-365.
2. Daniel H, Drevon CA, Klein UI, et al. The challenges for molecular nutrition research 3: comparative nutrigenomics research as a basis for entering the systems level. Genes Nutr 2008; 3-4:101-106.
3. Ordovas JM. Nutrigenetics, plasma lipids, and cardiovascular risk. J Am Diet Assoc 2006; 106:1074-1081.
4. Rimbach G, Minihane AM. Nutrigenetics and personalised nutrition: how far have we progressed and are we likely to get there? Proc Nutr Soc 2009. [Epub ahead of print] This paper clearly demonstrates the public health potential, but also the complexity of nutrigenetics reactions.
5. Capeau J. Insulin resistance and steatosis in humans. Diabetes Metab 2008; 34 (6 Pt 2):649-667.
6. Kotronen A, Yki-Jarvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 2008; 28:27-38.
7. Bansal S, Buring JE, Rifai N, et al. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 2007; 298:309-316.
8. Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 2007; 298:299-308.
9. Packard CJ. Small dense low-density lipoprotein and its role as an independent predictor of cardiovascular disease. Curr Opin Lipidol 2006; 17:412-417.
10. Rizzo M, Rini GB, Berneis K. The clinical relevance of LDL size and subclasses modulation in patients with type-2 diabetes. Exp Clin Endocrinol Diabetes 2007; 115:477-482.
11. Stalenhoef AF, de Graaf J. Association of fasting and nonfasting serum triglycerides with cardiovascular disease and the role of remnant-like lipoproteins and small dense LDL. Curr Opin Lipidol 2008; 19:355-461.
12. Minihane AM. Fatty acids, gene expression and coronary heart disease (CHD). In: Rimbach G, Fuchs J, Packer L, editors. Nutrigenomics. Boca Raton: Taylor and Francis Group; 2005. pp. 181-200.
13. Beisiegel U, Heeren J, Plas FS. Fatty acids and gene expression. In: Zempleni J, Daniel H, editors. Molecular Nutrition. Wallingford: CABI Publishing; 2003. pp. 121-134.
14. Jump DB, Botolin D, Wang Y, et al. Fatty acid regulation of hepatic gene transcription. J Nutr 2005; 135:2503-2506.
15. Jump DB, Botolin D, Wang Y, et al. Docosahexaenoic acid (DHA) and hepatic gene transcription. Chem Phys Lipids 2008; 153:3-13. This is an excellent overview of the most recent findings in the area of dietary fatty acids and hepatic gene expression, with a particular focus on SREBP1c regulation.
16. Issemann I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990; 347:645-650.
17. Pawar A, Jump DB. Unsaturated fatty acid regulation of peroxisome proliferator-activated receptor alpha activity in rat primary hepatocytes. J Biol Chem 2003; 278:35931-35939.
18. Krey G, Braissant O, L'Horset F, et al. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol Endocrinol 1997; 11:779-791.
19. Jump DB. N-3 polyunsaturated fatty acid regulation of hepatic gene transcription. Curr Opin Lipidol 2008; 19:242-247. A comprehensive overview of the impact of dietary n-3 polyunsaturated fatty acids on gene expression and transcription factor regulation.
20. Tarling E, Salter A, Bennett A. Transcriptional regulation of human SREBP-1c (sterol-regulatory-element-binding protein-1c): a key regulator of lipogenesis. Biochem Soc Trans 2004; 32 (Pt 1):107-109.
21. Wahle KW, Rotondo D, Heys SD. Polyunsaturated fatty acids and gene expression in mammalian systems. Proc Nutr Soc 2003; 62:349-360.
22. Clarke SD. The multidimensional regulation of gene expression by fatty acids: polyunsaturated fats as nutrient sensors. Curr Opin Lipidol 2004; 15:13-18.
23. Shimano H. SREBPs: novel aspects of SREBPs in the regulation of lipid synthesis. FEBS J 2009; 276:615.
24. Petrescu AD, Hertz R, Bar-Tana J, et al. Ligand specificity and conformational dependence of the hepatic nuclear factor-4alpha (HNF-4alpha). J Biol Chem 2002; 277:23988-23999.
25. Hertz R, Magenheim J, Berman I, Bar-Tana J. Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4alpha. Nature 1998; 392:512-516.
26. Jump DB, Clarke SD. Regulation of gene expression by dietary fat. Annu Rev Nutr 1999; 19:63-90.
27. Sato R. SREBPs: protein interaction and SREBPs. FEBS J 2009; 276:622-627.
28. Deckelbaum RJ, Worgall TS, Seo T. n-3 fatty acids and gene expression. Am J Clin Nutr 2006; 83 (6 Suppl):1520S-1525S.
29. Shimano H. SREBPs: physiology and pathophysiology of the SREBP family. FEBS J 2009; 276:616-621.
30. Caslake MJ, Miles EA, Kofler BM, et al. Effect of sex and genotype on cardiovascular biomarker response to fish oils: the FINGEN Study. Am J Clin Nutr 2008; 88:618-629. A clear example of an intervention trial, which examined diet composition genotype interaction, using a prospective recruitment by genotype approach.
31. Harris WS, Miller M, Tighe AP, et al. Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis 2008; 197:12-24.
32. Duval C, Muller M, Kersten S. PPARalpha and dyslipidemia. Biochim Biophys Acta 2007; 1771:961-971.
33. (NCEP) NCEP. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel 111): National Institutes of Health (NIH) 2002; 106: 3163-3223. Report No.: NIH 02-5215 Contract No.: Document Number.
34. Schaefer EJ, Lamon-Fava S, Ausman LM, et al. Individual variability in lipoprotein cholesterol response to National Cholesterol Education Program Step 2 diets. Am J Clin Nutr 1997; 65:630-823.
35. Masson LF, McNeill G, Avenell A. Genetic variation and the lipid response to dietary intervention: a systematic review. Am J Clin Nutr 2003; 77:1098-1111.
36. Wu K, Bowman R, Welch AA, Luben RN, et al. Apolipoprotein E polymorphisms, dietary fat and fibre, and serum lipids: the EPIC Norfolk study. Eur Heart J 2007; 28:2930-2936.
37. Minihane AM, Jofre-Monseny L, Olano-Martin E, Rimbach GH. Apolipoprotein E genotype, cardiovascular risk and responsiveness to dietary fat manipulation. Proc Nut Soc 2007; 66:183-197.
38. Olano-Martin E, Anil E, Caslake MJ, et al. Contribution of apolipoprotein E genotype and docosahexaenoic acid to the LDL-cholesterol response to fish oil. Atherosclerosis 2009 [Epub ahead of print]
39. Volcik KA, Nettleton JA, Ballantyne CM, Boerwinkle E. Peroxisome proliferator-activated receptor [alpha] genetic variation interacts with n-6 and longchain n-3 fatty acid intake to affect total cholesterol and LDL-cholesterol concentrations in the Atherosclerosis Risk in Communities Study. Am J Clin Nutr 2008; 87:1926-1931. Excellent example of the complexities of genotype-diet interactions, with the observed associations emerging as being highly dependent on ethnicity
40. Olano-Martin E, Abraham EC, Gill-Garrison R, et al. Influence of apoA-V gene variants on postprandial triglyceride metabolism: impact of gender. J Lipid Res 2008; 49:945-953.
41. Perez-Martinez P, Corella D, Shen J, et al. Association between glucokinase regulatory protein (GCKR) and apolipoprotein A5 (APOA5) gene polymorphisms and triacylglycerol concentrations in fasting, postprandial, and fenofi-brate-treated states. Am J Clin Nutr 2009; 89:391-399.
42. Perez-Martinez P, Lopez-Miranda J, Perez-Jimenez F, Ordovas JM. Influence of genetic factors in the modulation of postprandial lipemia. Atheroscler Suppl 2008; 9:49-55. This review provides a useful summary of current knowledge relating to the main genetic determinants of postprandial triglyceride clearance
43. Lindi V, Schwab U, Louheranta A, et al. Impact of the Pro12Ala polymorphism of the PPAR-gamma2 gene on serum triacylglycerol response to n-3 fatty acid supplementation. Mol Genet Metab 2003; 79:52-60.
44. Madden J, Carrero JJ, Brunner A, et al. Polymorphisms in the CD36 gene modulate the ability of fish oil supplements to lower fasting plasma triacyl glycerol and raise HDL cholesterol concentrations in healthy middle-aged men. Prostaglandins Leukot Essent Fatty Acids 2008; 78:327-335.
45. Minihane AM, Khan S, Leigh-Firbank EC, et al. ApoE polymorphism and fish oil supplementation in subjects with an atherogenic lipoprotein phenotype. Arterioscler Thromb Vasc Biol 2000; 20:1990-1997.